Epidemiology, risk factors, and opportunities for prevention of cardiovascular disease in individuals of South Asian ethnicity living in Europe
Por:
Cainzos-Achirica, M, Fedeli, U, Sattar, N, Agyemang, C, Jenum, AK, McEvoy, JW, Murphy, JD, Brotons, C, Elosua, R, Bilal, U, Kanaya, AM, Kandula, NR, Martinez-Amezcua, P, Comin-Colet, J, Pinto, X
Publicada:
1 jul 2019
Resumen:
South Asian (SA) individuals represent a large, growing population in a number of European countries. These individuals, particularly first-generation SA immigrants, are at higher risk of developing type 2 diabetes, atherogenic dyslipidaemia, and coronary heart disease than most other racial/ethnic groups living in Europe. SAs also have an increased risk of stroke compared to European-born individuals. Despite a large body of conclusive evidence, SA-specific cardiovascular health promotion and preventive interventions are currently scarce in most European countries, as well as at the European Union level. In this narrative review, we aim to increase awareness among clinicians and healthcare authorities of the public health importance of cardiovascular disease among SAs living in Europe, as well as the need for tailored interventions targeting this group particularly, in countries where SA immigration is a recent phenomenon. To this purpose, we review key studies on the epidemiology and risk factors of cardiovascular disease in SAs living in the United Kingdom, Italy, Spain, Denmark, Norway, Sweden, and other European countries. Building on these, we discuss potential opportunities for multi-level, targeted, tailored cardiovascular prevention strategies. Because lifestyle interventions often face important cultural barriers in SAs, particularly for first-generation immigrants; we also discuss features that may help maximise the effectiveness of those interventions. Finally, we evaluate knowledge gaps, currently available risk stratification tools such as QRISK-3, and future directions in this important field.
Filiaciones:
Cainzos-Achirica, M:
Bellvitge Univ Hosp, Dept Cardiol, Barcelona, Spain
Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain
Johns Hopkins Med Inst, Johns Hopkins Ciccarone Ctr Prevent Cardiovasc Di, Baltimore, MD 21205 USA
Univ Int Catalunya, Sch Med & Hlth Sci, Barcelona, Spain
Fedeli, U:
Azienda Zero, Dept Epidemiol, Padua, Veneto Region, Italy
Sattar, N:
Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
Agyemang, C:
Univ Amsterdam, Dept Publ Hlth, Amsterdam UMC, Amsterdam, Netherlands
Jenum, AK:
Univ Oslo, Inst Hlth & Soc, Dept Gen Practice, Gen Practice Res Unit AFE, Oslo, Norway
McEvoy, JW:
Johns Hopkins Med Inst, Johns Hopkins Ciccarone Ctr Prevent Cardiovasc Di, Baltimore, MD 21205 USA
Natl Univ Ireland, Galway, Ireland
Natl Inst Prevent Cardiol, Galway, Ireland
Univ Coll Hosp Galway, Saolta Univ Healthcare Grp, Dept Med, Div Cardiol, Galway, Ireland
Murphy, JD:
Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA
Brotons, C:
Ambit DAtencio Primaria Barcelona Ciutat, Casernes Primary Care Ctr, Barcelona, Spain
Elosua, R:
Mar Inst Med Res, Cardiovasc Epidemiol & Genet, Barcelona, Spain
Biomed Res Network Cardiovasc Dis CIBERCV, Barcelona, Spain
Univ Vic Cent Catalunya, Sch Med, Vic, Spain
Bilal, U:
Drexel Dornsife Sch Publ Hlth, Urban Hlth Collaborat, Philadelphia, PA USA
Kanaya, AM:
Univ Calif San Francisco, San Francisco, CA 94143 USA
Kandula, NR:
Northwestern Univ, Dept Med, Chicago, IL 60611 USA
Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA
Martinez-Amezcua, P:
Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
Comin-Colet, J:
Bellvitge Univ Hosp, Dept Cardiol, Barcelona, Spain
Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain
Univ Barcelona, Sch Med, Barcelona, Spain
Pinto, X:
Univ Barcelona, Sch Med, Barcelona, Spain
Bellvitge Univ Hosp, Dept Internal Med, Cardiovasc Risk Unit, Barcelona, Spain
Inst Salud Carlos III, Biomed Res Network Obes & Nutr CIBEROBN, Madrid, Spain
Green Accepted
|